請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99860完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 張慶國 | zh_TW |
| dc.contributor.advisor | Chin-Kuo Chang | en |
| dc.contributor.author | 劉馨鎂 | zh_TW |
| dc.contributor.author | Hsin-Mei Liu | en |
| dc.date.accessioned | 2025-09-19T16:07:12Z | - |
| dc.date.available | 2025-09-20 | - |
| dc.date.copyright | 2025-09-19 | - |
| dc.date.issued | 2025 | - |
| dc.date.submitted | 2025-07-25 | - |
| dc.identifier.citation | 1. Zumstein, N. and F. Riese, Defining Severe and Persistent Mental Illness-A Pragmatic Utility Concept Analysis. Front Psychiatry, 2020. 11: p. 648.
2. Owen, M.J., A. Sawa, and P.B. Mortensen, Schizophrenia. Lancet, 2016. 388(10039): p. 86-97. 3. McGrath, J., et al., Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev, 2008. 30: p. 67-76. 4. Grande, I., et al., Bipolar disorder. Lancet, 2016. 387(10027): p. 1561-1572. 5. Wy, T.J.P. and A. Saadabadi, Schizoaffective Disorder, in StatPearls. 2025: Treasure Island (FL) ineligible companies. Disclosure: Abdolreza Saadabadi declares no relevant financial relationships with ineligible companies. 6. Pahwa, M., et al., Cardiometabolic and endocrine comorbidities in women with bipolar disorder: A systematic review. J Affect Disord, 2023. 323: p. 841-859. 7. M, D.E.H., et al., Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 2011. 10(1): p. 52-77. 8. Howard, L.M., et al., Domestic violence and severe psychiatric disorders: prevalence and interventions. Psychol Med, 2010. 40(6): p. 881-93. 9. Wieck, A. and P.M. Haddad, Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry, 2003. 182: p. 199-204. 10. Korchia, T., et al., Sexual Dysfunction in Schizophrenia: A Systematic Review and Meta-Analysis. JAMA Psychiatry, 2023. 80(11): p. 1110-1120. 11. Costa, B. and N. Vale, Advances in Psychotropic Treatment for Pregnant Women: Efficacy, Adverse Outcomes, and Therapeutic Monitoring. J Clin Med, 2024. 13(15). 12. Keepers, G.A., et al., The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. Am J Psychiatry, 2020. 177(9): p. 868-872. 13. Hope, H., et al., The sexual and reproductive health of women with mental illness: a primary care registry study. Arch Womens Ment Health, 2022. 25(3): p. 585-593. 14. Sisodia, S., et al., Sexual and reproductive health needs of women with severe mental illness in low- and middle-income countries: A scoping review. PLoS One, 2025. 20(1): p. e0311554. 15. Brown, C.C., et al., Mental Health Conditions Increase Severe Maternal Morbidity By 50 Percent And Cost $102 Million Yearly In The United States. Health Aff (Millwood), 2021. 40(10): p. 1575-1584. 16. Howard, L.M. and H. Khalifeh, Perinatal mental health: a review of progress and challenges. World Psychiatry, 2020. 19(3): p. 313-327. 17. MacBeth, A., et al., General and age-specific fertility rates in non-affective psychosis: population-based analysis of Scottish women. Soc Psychiatry Psychiatr Epidemiol, 2023. 58(1): p. 105-112. 18. Bundy, H., D. Stahl, and J.H. MacCabe, A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives. Acta Psychiatr Scand, 2011. 123(2): p. 98-106. 19. Power, R.A., et al., Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. JAMA Psychiatry, 2013. 70(1): p. 22-30. 20. Yang, H.S., et al., Risk of teenage pregnancy among adolescents with bipolar disorder: a cohort study of 35,398 adolescent girls. Eur Child Adolesc Psychiatry, 2023. 32(10): p. 2001-2008. 21. Krogh, H.B., et al., Bipolar disorder and sexuality: a preliminary qualitative pilot study. Int J Bipolar Disord, 2023. 11(1): p. 5. 22. Marengo, E., et al., Unplanned pregnancies and reproductive health among women with bipolar disorder. J Affect Disord, 2015. 178: p. 201-5. 23. Sweeting, A., et al., A Clinical Update on Gestational Diabetes Mellitus. Endocr Rev, 2022. 43(5): p. 763-793. 24. Beka, Q., et al., Development of Perinatal Mental Illness in Women With Gestational Diabetes Mellitus: A Population-Based Cohort Study. Can J Diabetes, 2018. 42(4): p. 350-355 e1. 25. Riggin, L., Association Between Gestational Diabetes and Mental Illness. Can J Diabetes, 2020. 44(6): p. 566-571 e3. 26. Rummel-Kluge, C., et al., Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res, 2010. 123(2-3): p. 225-33. 27. Galbally, M., et al., The association between gestational diabetes mellitus, antipsychotics and severe mental illness in pregnancy: A multicentre study. Aust N Z J Obstet Gynaecol, 2020. 60(1): p. 63-69. 28. Heinonen, E., et al., Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden. CNS Drugs, 2022. 36(5): p. 529-539. 29. Wang, Z., et al., The use of antipsychotic agents during pregnancy and the risk of gestational diabetes mellitus: a systematic review and meta-analysis. Psychol Med, 2021. 51(6): p. 1028-1037. 30. Nguyen, T.N., et al., Obstetric and neonatal outcomes of pregnant women with severe mental illness at a specialist antenatal clinic. Med J Aust, 2013. 199(3 Suppl): p. S26-9. 31. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol, 2020. 135(6): p. e237-e260. 32. Lissaker, C., et al., Occupational stress and pregnancy-related hypertension and diabetes: Results from a nationwide prospective cohort. Scand J Work Environ Health, 2022. 48(3): p. 239-247. 33. Petersen, I., et al., Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess, 2016. 20(23): p. 1-176. 34. Frayne, J., et al., The association between mental illness, psychotropic medication use and hypertensive disorders in pregnancy: A multicentre study. Pregnancy Hypertens, 2021. 24: p. 22-26. 35. Deer, E., et al., The role of immune cells and mediators in preeclampsia. Nat Rev Nephrol, 2023. 19(4): p. 257-270. 36. Schur, E., et al., Placental abruption: assessing trends in risk factors over time. Arch Gynecol Obstet, 2022. 306(5): p. 1547-1554. 37. Ananth, C.V., D.A. Savitz, and E.R. Luther, Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy. Am J Epidemiol, 1996. 144(9): p. 881-9. 38. Leone, J.M., et al., Effects of intimate partner violence on pregnancy trauma and placental abruption. J Womens Health (Larchmt), 2010. 19(8): p. 1501-9. 39. Chen, D., et al., Independent risk factors for placental abruption: a systematic review and meta-analysis. BMC Pregnancy Childbirth, 2025. 25(1): p. 351. 40. Ohuma, E.O., et al., National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet, 2023. 402(10409): p. 1261-1271. 41. Andersson, N.W., et al., Influence of prenatal maternal stress on umbilical cord blood cytokine levels. Arch Womens Ment Health, 2016. 19(5): p. 761-7. 42. Gayle, D.A., et al., Maternal LPS induces cytokines in the amniotic fluid and corticotropin releasing hormone in the fetal rat brain. Am J Physiol Regul Integr Comp Physiol, 2004. 286(6): p. R1024-9. 43. Tosato, S., et al., A Systematized Review of Atypical Antipsychotics in Pregnant Women: Balancing Between Risks of Untreated Illness and Risks of Drug-Related Adverse Effects. J Clin Psychiatry, 2017. 78(5): p. e477-e489. 44. Boden, R., et al., Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ, 2012. 345: p. e7085. 45. Kelly, R.H., et al., Psychiatric and substance use disorders as risk factors for low birth weight and preterm delivery. Obstet Gynecol, 2002. 100(2): p. 297-304. 46. Schlaudecker, E.P., et al., Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine, 2017. 35(48 Pt A): p. 6518-6528. 47. Shriyan, P., et al., Association of high cortisol levels in pregnancy and altered fetal growth. Results from the MAASTHI, a prospective cohort study, Bengaluru. Lancet Reg Health Southeast Asia, 2023. 14: p. 100196. 48. Figueras, F., et al., Association of smoking during pregnancy and fetal growth restriction: subgroups of higher susceptibility. Eur J Obstet Gynecol Reprod Biol, 2008. 138(2): p. 171-5. 49. Ciesielski, T.H., C.J. Marsit, and S.M. Williams, Maternal psychiatric disease and epigenetic evidence suggest a common biology for poor fetal growth. BMC Pregnancy Childbirth, 2015. 15: p. 192. 50. Okwaraji, Y.B., et al., National, regional, and global estimates of low birthweight in 2020, with trends from 2000: a systematic analysis. Lancet, 2024. 403(10431): p. 1071-1080. 51. Boden, R., et al., Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. Arch Gen Psychiatry, 2012. 69(7): p. 715-21. 52. Lin, H.Y., et al., Antipsychotic Use in Early Pregnancy and the Risk of Maternal and Neonatal Complications. Mayo Clin Proc, 2022. 97(11): p. 2086-2096. 53. Tavares Da Silva, F., et al., Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine, 2016. 34(49): p. 6057-6068. 54. Adane, A.A., et al., The impact of maternal prenatal mental health disorders on stillbirth and infant mortality: a systematic review and meta-analysis. Arch Womens Ment Health, 2021. 24(4): p. 543-555. 55. Hoch, D., et al., Maternal Smoking in the First Trimester and its Consequence on the Early Placenta. Lab Invest, 2023. 103(5): p. 100059. 56. Miller, C.B. and T. Wright, Investigating Mechanisms of Stillbirth in the Setting of Prenatal Substance Use. Acad Forensic Pathol, 2018. 8(4): p. 865-873. 57. DeSilva, M., et al., Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, 2016. 34(49): p. 6015-6026. 58. Straub, L., et al., Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort Study. JAMA Intern Med, 2022. 182(5): p. 522-533. 59. Wang, E., et al., Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes. CNS Drugs, 2025. 39(1): p. 1-22. 60. Patorno, E., K.F. Huybrechts, and S. Hernandez-Diaz, Lithium Use in Pregnancy and the Risk of Cardiac Malformations. N Engl J Med, 2017. 377(9): p. 893-894. 61. Nielsen, A.M., C.S. Stika, and K.L. Wisner, Perinatal psychiatry: balancing maternal-fetal exposures to mental disorders and drug treatments. Semin Perinatol, 2025: p. 152076. 62. Frayne, J., et al., Obstetric outcomes for women with severe mental illness: 10 years of experience in a tertiary multidisciplinary antenatal clinic. Arch Gynecol Obstet, 2019. 300(4): p. 889-896. 63. Page, M.J., et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021. 372: p. n71. 64. Stang, A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010. 25(9): p. 603-5. 65. Huedo-Medina, T.B., et al., Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods, 2006. 11(2): p. 193-206. 66. Bakbergenuly, I., D.C. Hoaglin, and E. Kulinskaya, Methods for estimating between-study variance and overall effect in meta-analysis of odds ratios. Res Synth Methods, 2020. 11(3): p. 426-442. 67. Lin, L. and H. Chu, Quantifying publication bias in meta-analysis. Biometrics, 2018. 74(3): p. 785-794. 68. Vigod, S.N., et al., Temporal trends in general and age-specific fertility rates among women with schizophrenia (1996-2009): a population-based study in Ontario, Canada. Schizophr Res, 2012. 139(1-3): p. 169-75. 69. Canada, S. Report on the Demographic Situation in Canada 2024. 2024 [cited 2025 July 16]; Available from: https://www150.statcan.gc.ca/n1/pub/91f0015m/91f0015m2024001-eng.htm#a4. 70. Statista. Total fertility rate in Scotland from 2000 to 2023. 2024 [cited 2025 July 16]; Available from: https://www.statista.com/statistics/367781/total-fertility-rate-in-scotland/. 71. Chan, J.K.N., et al., Adverse obstetric and neonatal outcomes associated with maternal schizophrenia-spectrum disorders and prenatal antipsychotic use: a meta-analysis of 37,214,330 pregnancy deliveries and propensity-score weighted population-based cohort study assessing confounder dependency of risk estimates. Mol Psychiatry, 2025. 30(3): p. 954-967. 72. Etchecopar-Etchart, D., et al., Maternal and neonatal complications of pregnant women with bipolar disorder: a systematic review and meta-analysis. EClinicalMedicine, 2025. 79: p. 103007. 73. Psychiatrists, R.C.o. Perinatal Mental Health Services: Recommendations for Psychiatrists (CR232). 2021 [cited 2025 June 11]; Available from: https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/college-reports/college-report-cr232---perinatal-mental-heath-services.pdf. 74. Hamoda H, P.A., Preconception Counseling., in StatPearls [Internet]. 2023, StatPearls Publishing: Treasure Island (FL). 75. (UK), N.C.C.f.M.H., Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance, U. edition, Editor. 2018, National Institute for Health and Care Excellence (UK): London. 76. Rolnik, D.L., et al., Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med, 2017. 377(7): p. 613-622. 77. Howard, L.M., et al., Non-psychotic mental disorders in the perinatal period. Lancet, 2014. 384(9956): p. 1775-88. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99860 | - |
| dc.description.abstract | 背景：嚴重精神疾病的定義，一般包含思覺失調、躁鬱症及情感性精神疾病等，罹患研究嚴重精神疾病的育齡女性存在著生育力下降與不良產科及新生兒出生結果風險上升的情形，但結果並未完全一致。目的：本研究旨在以人口群的角度，比較嚴重精神疾病育齡女性之總生育率，並探討嚴重精神疾病與孕期併發症、新生兒出生結果之間的相關性。
材料與方法：本研究為一項系統性回顧與統合分析，納入2000年至2024年間國際學術期刊發表的觀察性研究。分析結果包含總生育率、妊娠糖尿病、妊娠高血壓、子癲前症、胎盤早期剝離、胎死腹中、早產、出生時小於妊娠年齡、低出生體重及先天性畸形等具有公共衛生與臨床重要性的指標。 結果：統合分析顯示，嚴重精神疾病育齡女性患者的總生育率顯著低於一般女性，且其妊娠與新生兒併發症的風險有顯著提高。整體風險比在早產、出生時小於妊娠年齡、低出生體重、死產、先天性畸形、妊娠糖尿病與妊娠高血壓等不良後果的風險皆顯著上升。然而，部分結果也顯示出潛在存有發表偏差的現象。 結論：處於育齡之嚴重精神疾病女性患者為不利生殖健康的高風險族群，需整合精神醫療與周產期照護、懷孕期檢查與早期產前篩檢，以及針對精神疾病污名化與該群婦女潛在就醫障礙之公衛介入策略。 | zh_TW |
| dc.description.abstract | Background: Women of severe mental illness (SMI), including schizophrenia, bipolar disorder, and schizoaffective disorder, at childbearing age were found to experience reduced fertility and increased risks of adverse obstetric and neonatal outcomes without full consistency.
Objectives: This study aimed to assess the total fertility rate (TFR) in women with SMI and to examine the associations between SMI and pregnancy/neonatal complications. Methods: We conducted a systematic review and meta-analysis of observational studies published in academic journals from 2000 to 2024. Outcomes included TFR, gestational diabetes mellitus, gestational hypertension, preeclampsia, placental abruption, stillbirth, preterm birth, small-for-gestational-age, low birth weight, and congenital malformation. Results: Meta-analysis showed that women with SMI had significantly lower TFR and higher relative risks of gestational and neonatal complications. Pooled risk ratios were elevated for preterm birth, small-for-gestational-age, low birth weight, stillbirth, congenital malformation, gestational diabetes mellitus, and gestational hypertension. However, publication bias was detected for some specific outcomes. Conclusion: Women with SMI represent a high-risk group with reproductive vulnerability. Integrated psychiatric and perinatal care, clinical exams in each trimester, early prenatal screening, and public health strategies addressing the stigma of mental disorders and healthcare service access are urgently needed for this group of people. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2025-09-19T16:07:12Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2025-09-19T16:07:12Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 誌謝 i
中文摘要及關鍵詞 ii Abstract and keywords iii Table of contents iv Chapter 1. Introduction 1 Chapter 2. Materials and Methods 14 Chapter 3. Results 17 Chapter 4. Discussion 33 References 41 Supplementary Material 46 Figures: Figure 1. PRISMA 2020 flow diagram outlining the identification, screening, and inclusion process for studies in the systematic review and meta-analysis. The diagram demonstrates the systematic identification of 21 eligible studies 21 Figure 2. Forest plot presenting mean and 95% confidence intervals (CIs) for associations between the total fertility rate of SMI women 30 Figure 3. Forest plot presenting risk ratio (RR) and 95% confidence intervals (CIs) for associations between the obstetric outcomes of SMI women 31 Figure 4. Forest plot presenting risk ratio (RR) and 95% confidence intervals (CIs) for associations between the neonatal outcomes of SMI women 32 Tables: Table 1. Characteristics of the included studies of age-specific fertility rate for systematic review 22 Table 2. Characteristics of the included studies of obstetric and neonatal outcomes for systematic review 23 Table 3. Assess study quality using the Newcastle–Ottawa Scale for cohort studies 29 | - |
| dc.language.iso | en | - |
| dc.subject | 高危險妊娠 | zh_TW |
| dc.subject | 系統性回顧與統合分析 | zh_TW |
| dc.subject | 新生兒併發症 | zh_TW |
| dc.subject | 嚴重精神疾病 | zh_TW |
| dc.subject | 總生育率 | zh_TW |
| dc.subject | systematic review and meta-analysis | en |
| dc.subject | severe mental illness | en |
| dc.subject | total fertility rate | en |
| dc.subject | adverse obstetric outcomes | en |
| dc.subject | neonatal outcomes | en |
| dc.title | 嚴重精神疾病女性患者的總生育率、不良產科與新生兒結果：一項系統性文獻回顧與統合分析 | zh_TW |
| dc.title | Total Fertility Rate, Adverse Obstetric and Neonatal Outcomes for Women of Severe Mental Illness: a Systematic Review and Meta-analysis | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 113-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 曾翎威;蕭聖謀 | zh_TW |
| dc.contributor.oralexamcommittee | Ling-Wei Chen;Sheng-Mou Hsiao | en |
| dc.subject.keyword | 嚴重精神疾病,總生育率,高危險妊娠,新生兒併發症,系統性回顧與統合分析, | zh_TW |
| dc.subject.keyword | severe mental illness,total fertility rate,adverse obstetric outcomes,neonatal outcomes,systematic review and meta-analysis, | en |
| dc.relation.page | 74 | - |
| dc.identifier.doi | 10.6342/NTU202502460 | - |
| dc.rights.note | 同意授權(限校園內公開) | - |
| dc.date.accepted | 2025-07-28 | - |
| dc.contributor.author-college | 公共衛生學院 | - |
| dc.contributor.author-dept | 流行病學與預防醫學研究所 | - |
| dc.date.embargo-lift | 2030-07-24 | - |
| 顯示於系所單位： | 流行病學與預防醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-113-2.pdf 未授權公開取用 | 8.62 MB | Adobe PDF | 檢視/開啟 |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。